{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:48:13Z","timestamp":1786632493107,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370659"],"award-info":[{"award-number":["82370659"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172167"],"award-info":[{"award-number":["82172167"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) remains a major global health burden with limited therapeutic options. Heat shock factor 2 binding protein (HSF2BP), originally characterized as a germ cell-specific regulator of meiosis, is significantly upregulated in both MASLD patient livers and high-fat diet (HFD)-fed mice. Here, we identify HSF2BP as a key metabolic regulator in hepatocytes that alleviates hepatic lipid accumulation by enhancing mitochondrial function. Hepatocyte-specific overexpression of HSF2BP improves glucose tolerance, reduces lipid deposition, and increases mitochondrial respiration, whereas its knockout exacerbates steatosis. Mechanistically, we show that HSF2BP undergoes SUMOylation through interaction with UBC9, promoting its nuclear translocation and triggering an upregulation of COX6A1, a core subunit of mitochondrial complex IV. This process is impaired in MASLD due to global suppression of hepatic SUMOylation. Pharmacological inhibition of SUMOylation using TAK-981 abolishes the protective effect of HSF2BP against hepatic steatosis, whereas enhancing SUMOylation through UBC9 overexpression or treatment with the SUMO activator N106 markedly ameliorates lipid accumulation in the liver. Collectively, our findings uncover a SUMOylation-dependent mechanism by which HSF2BP regulates mitochondrial integrity and lipid homeostasis, providing a promising therapeutic axis for MASLD.<\/jats:p>","DOI":"10.1038\/s41419-026-08935-3","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:34:14Z","timestamp":1780936454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SUMOylation-driven nuclear translocation of HSF2BP alleviates MASLD via COX6A1-dependent mitochondrial reprogramming"],"prefix":"10.1038","volume":"17","author":[{"given":"Mengzhou","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhou","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2507-8168","authenticated-orcid":false,"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0993-4531","authenticated-orcid":false,"given":"Rongqian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"8935_CR1","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542\u201356.","journal-title":"J Hepatol"},{"key":"8935_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8935_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD, Cao YY, Zheng MH. Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab. 2024;35:697\u2013707.","journal-title":"Trends Endocrinol Metab"},{"key":"8935_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","volume":"78","author":"B Fromenty","year":"2023","unstructured":"Fromenty B, Roden M. Mitochondrial alterations in fatty liver diseases. J Hepatol. 2023;78:415\u201329.","journal-title":"J Hepatol"},{"key":"8935_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","volume":"152","author":"Z Chen","year":"2020","unstructured":"Chen Z, Tian R, She Z, Cai J, Li H. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med. 2020;152:116\u201341.","journal-title":"Free Radic Biol Med"},{"key":"8935_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102643","volume":"61","author":"L Goicoechea","year":"2023","unstructured":"Goicoechea L, Conde de la Rosa L, Torres S, Garc\u00eda-Ruiz C, Fern\u00e1ndez-Checa JC. Mitochondrial cholesterol: metabolism and impact on redox biology and disease. Redox Biol. 2023;61:102643.","journal-title":"Redox Biol"},{"key":"8935_CR7","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","volume":"69","author":"C Lebeaupin","year":"2018","unstructured":"Lebeaupin C, Vall\u00e9e D, Hazari Y, Hetz C, Chevet E, Bailly-Maitre B. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 2018;69:927\u201347.","journal-title":"J Hepatol"},{"key":"8935_CR8","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/hep.32562","volume":"77","author":"A Ajoolabady","year":"2023","unstructured":"Ajoolabady A, Kaplowitz N, Lebeaupin C, Kroemer G, Kaufman RJ, Malhi H, et al. Endoplasmic reticulum stress in liver diseases. Hepatology. 2023;77:619\u201339.","journal-title":"Hepatology"},{"key":"8935_CR9","doi-asserted-by":"crossref","unstructured":"Pedroza-Diaz J, Arroyave-Ospina JC, Serna Salas S, Moshage H. Modulation of oxidative stress-induced senescence during non-alcoholic fatty liver disease. Antioxidants. 2022;11:975.","DOI":"10.3390\/antiox11050975"},{"key":"8935_CR10","doi-asserted-by":"crossref","unstructured":"Di Ciaula A, Passarella S, Shanmugam H, Noviello M, Bonfrate L, Wang DQ, et al. Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as players and targets of therapies? Int J Mol Sci. 2021;22:5375.","DOI":"10.3390\/ijms22105375"},{"key":"8935_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201900043","volume":"63","author":"Z Li","year":"2019","unstructured":"Li Z, Li Y, Zhang HX, Guo JR, Lam CWK, Wang CY, et al. Mitochondria-mediated pathogenesis and therapeutics for non-alcoholic fatty liver disease. Mol Nutr Food Res. 2019;63:e1900043.","journal-title":"Mol Nutr Food Res"},{"key":"8935_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13622","volume":"52","author":"A Karkucinska-Wieckowska","year":"2022","unstructured":"Karkucinska-Wieckowska A, Simoes ICM, Kalinowski P, Lebiedzinska-Arciszewska M, Zieniewicz K, Milkiewicz P, et al. Mitochondria, oxidative stress and nonalcoholic fatty liver disease: a complex relationship. Eur J Clin Investig. 2022;52:e13622.","journal-title":"Eur J Clin Investig"},{"key":"8935_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107980","volume":"221","author":"R Luo","year":"2025","unstructured":"Luo R, Yang Y, Zhang Y, Xue X, Guo M, Li X. Mitochondrial damage-associated molecular patterns (mito-DAMPs): determinants of hepatopathy progression and therapeutic implications. Pharmacol Res. 2025;221:107980.","journal-title":"Pharmacol Res"},{"key":"8935_CR14","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1016\/j.celrep.2019.05.096","volume":"27","author":"I Brandsma","year":"2019","unstructured":"Brandsma I, Sato K, van Rossum-Fikkert SE, van Vliet N, Sleddens E, Reuter M, et al. HSF2BP interacts with a conserved domain of BRCA2 and is required for mouse spermatogenesis. Cell Rep. 2019;27:3790\u20138.e7.","journal-title":"Cell Rep"},{"key":"8935_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0378-1119(98)00208-X","volume":"214","author":"T Yoshima","year":"1998","unstructured":"Yoshima T, Yura T, Yanagi H. Novel testis-specific protein that interacts with heat shock factor 2. Gene. 1998;214:139\u201346.","journal-title":"Gene"},{"key":"8935_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13578-023-01010-w","volume":"13","author":"J Zhang","year":"2023","unstructured":"Zhang J, Wang T, Bi J, Ke M, Ren Y, Wang M, et al. Overexpression of HSF2 binding protein suppresses endoplasmic reticulum stress via regulating subcellular localization of CDC73 in hepatocytes. Cell Biosci. 2023;13:64.","journal-title":"Cell Biosci"},{"key":"8935_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05282-x","volume":"13","author":"J Bi","year":"2022","unstructured":"Bi J, Zhang J, Ke M, Wang T, Wang M, Liu W, et al. HSF2BP protects against acute liver injury by regulating HSF2\/HSP70\/MAPK signaling in mice. Cell Death Dis. 2022;13:830.","journal-title":"Cell Death Dis"},{"key":"8935_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08676-2","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang J, Fujiwara Y, Yamamoto S, Shibuya H. A meiosis-specific BRCA2 binding protein recruits recombinases to DNA double-strand breaks to ensure homologous recombination. Nat Commun. 2019;10:722.","journal-title":"Nat Commun"},{"key":"8935_CR19","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1093\/nar\/gkz1219","volume":"48","author":"K Sato","year":"2020","unstructured":"Sato K, Brandsma I, van Rossum-Fikkert SE, Verkaik N, Oostra AB, Dorsman JC, et al. HSF2BP negatively regulates homologous recombination in DNA interstrand crosslink repair. Nucleic Acids Res. 2020;48:2442\u201356.","journal-title":"Nucleic Acids Res"},{"key":"8935_CR20","doi-asserted-by":"crossref","unstructured":"Felipe-Medina N, Caburet S, S\u00e1nchez-S\u00e1ez F, Condezo YB, de Rooij DG, G\u00f3mez HL, et al. A missense in HSF2BP causing primary ovarian insufficiency affects meiotic recombination by its novel interactor C19ORF57\/BRME1. eLife. 2020;9:e56996.","DOI":"10.7554\/eLife.56996"},{"key":"8935_CR21","doi-asserted-by":"publisher","first-page":"10324","DOI":"10.1080\/21655979.2022.2063561","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Zhang Y, Tao J, Yu T, Zhang T. Heat shock factor 2-binding protein promotes tumor progression via activation of MAPK signaling pathway in lung adenocarcinoma. Bioengineered. 2022;13:10324\u201334.","journal-title":"Bioengineered"},{"key":"8935_CR22","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.21037\/atm-21-4935","volume":"9","author":"Z Huang","year":"2021","unstructured":"Huang Z, Liu Z, Cheng X, Han Z, Li J, Xia T, et al. Prognostic significance of HSF2BP in lung adenocarcinoma. Ann Transl Med. 2021;9:1559.","journal-title":"Ann Transl Med"},{"key":"8935_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/bioinformatics\/btw624","volume":"33","author":"JW Nelson","year":"2017","unstructured":"Nelson JW, Sklenar J, Barnes AP, Minnier J. The START App: a web-based RNAseq analysis and visualization resource. Bioinformatics. 2017;33:447\u20139.","journal-title":"Bioinformatics"},{"key":"8935_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116898","volume":"177","author":"M Li","year":"2024","unstructured":"Li M, Zhang J, Li Z, Xu Z, Qian S, Tay LJ, et al. The role and mechanism of SUMO modification in liver disease. Biomed Pharmacother. 2024;177:116898.","journal-title":"Biomed Pharmacother"},{"key":"8935_CR25","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1002\/hep.31881","volume":"74","author":"Y Liu","year":"2021","unstructured":"Liu Y, Dou X, Zhou WY, Ding M, Liu L, Du RQ, et al. Hepatic Small Ubiquitin-Related Modifier (SUMO)-specific protease 2 controls systemic metabolism through SUMOylation-dependent regulation of liver-adipose tissue crosstalk. Hepatology. 2021;74:1864\u201383.","journal-title":"Hepatology"},{"key":"8935_CR26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41580-022-00500-y","volume":"23","author":"ACO Vertegaal","year":"2022","unstructured":"Vertegaal ACO. Signalling mechanisms and cellular functions of SUMO. Nat Rev Mol Cell Biol. 2022;23:715\u201331.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8935_CR27","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1021\/acs.jmedchem.0c01491","volume":"64","author":"SP Langston","year":"2021","unstructured":"Langston SP, Grossman S, England D, Afroze R, Bence N, Bowman D, et al. Discovery of TAK-981, a first-in-class inhibitor of SUMO-activating enzyme for the treatment of cancer. J Med Chem. 2021;64:2501\u201320.","journal-title":"J Med Chem"},{"key":"8935_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aba7791","volume":"13","author":"ES Lightcap","year":"2021","unstructured":"Lightcap ES, Yu P, Grossman S, Song K, Khattar M, Xega K, et al. A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models. Sci Transl Med. 2021;13:eaba7791.","journal-title":"Sci Transl Med"},{"key":"8935_CR29","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/s41388-025-03305-3","volume":"44","author":"E Valima","year":"2025","unstructured":"Valima E, Varis V, Bureiko K, Lempi\u00e4inen JK, Schroderus AM, Oksa L, et al. SUMOylation inhibition potentiates the glucocorticoid receptor to program growth arrest of acute lymphoblastic leukemia cells. Oncogene. 2025;44:1259\u201371.","journal-title":"Oncogene"},{"key":"8935_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40164-022-00293-y","volume":"11","author":"W Hanel","year":"2022","unstructured":"Hanel W, Lata P, Youssef Y, Tran H, Tsyba L, Sehgal L, et al. A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells. Exp Hematol Oncol. 2022;11:40.","journal-title":"Exp Hematol Oncol"},{"key":"8935_CR31","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1093\/nar\/gkm617","volume":"35","author":"A Jakobs","year":"2007","unstructured":"Jakobs A, Himstedt F, Funk M, Korn B, Gaestel M, Niedenthal R. Ubc9 fusion-directed SUMOylation identifies constitutive and inducible SUMOylation. Nucleic Acids Res. 2007;35:e109.","journal-title":"Nucleic Acids Res"},{"key":"8935_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8229","volume":"6","author":"C Kho","year":"2015","unstructured":"Kho C, Lee A, Jeong D, Oh JG, Gorski PA, Fish K, et al. Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure. Nat Commun. 2015;6:7229.","journal-title":"Nat Commun"},{"key":"8935_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148740","volume":"927","author":"H Xu","year":"2024","unstructured":"Xu H, Xu B. UBE2I regulates the nuclear translocation of hnRNPA2B1 by contributing to SUMO modification in osteoarthritis. Gene. 2024;927:148740.","journal-title":"Gene"},{"key":"8935_CR34","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nature20157","volume":"539","author":"S Cogliati","year":"2016","unstructured":"Cogliati S, Calvo E, Loureiro M, Guaras AM, Nieto-Arellano R, Garcia-Poyatos C, et al. Mechanism of super-assembly of respiratory complexes III and IV. Nature. 2016;539:579\u201382.","journal-title":"Nature"},{"key":"8935_CR35","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1080\/15548627.2020.1851492","volume":"17","author":"P Luo","year":"2021","unstructured":"Luo P, Yan H, Du J, Chen X, Shao J, Zhang Y, et al. PLK1 (polo like kinase 1)-dependent autophagy facilitates gefitinib-induced hepatotoxicity by degrading COX6A1 (cytochrome c oxidase subunit 6A1). Autophagy. 2021;17:3221\u201337.","journal-title":"Autophagy"},{"key":"8935_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07253-0","volume":"23","author":"T Yu","year":"2025","unstructured":"Yu T, Fang Z, Cheng Y, Zhou Y, Ji Y, Liu C. A novel palmitoylation-based molecular signature reveals COX6A1 as a key regulator in metabolic dysfunction-associated steatotic liver disease. J Transl Med. 2025;23:1212.","journal-title":"J Transl Med"},{"key":"8935_CR37","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic Fatty Liver Disease 2020: the state of the disease. Gastroenterology. 2020;158:1851\u201364.","journal-title":"Gastroenterology"},{"key":"8935_CR38","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79:516\u201337.","journal-title":"J Hepatol"},{"key":"8935_CR39","doi-asserted-by":"crossref","unstructured":"Singh MK, Shin Y, Ju S, Han S, Choe W, Yoon KS, et al. Heat shock response and heat shock proteins: current understanding and future opportunities in human diseases. Int J Mol Sci. 2024;25:4209.","DOI":"10.3390\/ijms25084209"},{"key":"8935_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04273-w","volume":"26","author":"F Wang","year":"2022","unstructured":"Wang F, Zhang Y, Li J, Xia H, Zhang D, Yao S. The pathogenesis and therapeutic strategies of heat stroke-induced liver injury. Crit Care. 2022;26:391.","journal-title":"Crit Care"},{"key":"8935_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111067","volume":"135","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhang X, Huang W, Ge X. The role of heat shock proteins in the regulation of fibrotic diseases. Biomed Pharmacother. 2021;135:111067.","journal-title":"Biomed Pharmacother"},{"key":"8935_CR42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.mito.2020.10.004","volume":"58","author":"B Kadenbach","year":"2021","unstructured":"Kadenbach B. Complex IV - The regulatory center of mitochondrial oxidative phosphorylation. Mitochondrion. 2021;58:296\u2013302.","journal-title":"Mitochondrion"},{"key":"8935_CR43","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ajhg.2014.07.013","volume":"95","author":"G Tamiya","year":"2014","unstructured":"Tamiya G, Makino S, Hayashi M, Abe A, Numakura C, Ueki M, et al. A mutation of COX6A1 causes a recessive axonal or mixed form of Charcot-Marie-Tooth disease. Am J Hum Genet. 2014;95:294\u2013300.","journal-title":"Am J Hum Genet"},{"key":"8935_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bbrc.2008.05.178","volume":"373","author":"SY Eun","year":"2008","unstructured":"Eun SY, Woo IS, Jang HS, Jin H, Kim MY, Kim HJ, et al. Identification of cytochrome c oxidase subunit 6A1 as a suppressor of Bax-induced cell death by yeast-based functional screening. Biochem Biophys Res Commun. 2008;373:58\u201363.","journal-title":"Biochem Biophys Res Commun"},{"key":"8935_CR45","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1152\/physrev.00025.2019","volume":"100","author":"HM Chang","year":"2020","unstructured":"Chang HM, Yeh ETH. SUMO: from bench to bedside. Physiol Rev. 2020;100:1599\u2013619.","journal-title":"Physiol Rev"},{"key":"8935_CR46","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.cca.2020.07.044","volume":"510","author":"M Zeng","year":"2020","unstructured":"Zeng M, Liu W, Hu Y, Fu N. Sumoylation in liver disease. Clin Chim Acta. 2020;510:347\u201353.","journal-title":"Clin Chim Acta"},{"key":"8935_CR47","doi-asserted-by":"crossref","unstructured":"He J, Cheng J, Wang T. SUMOylation-mediated response to mitochondrial stress. Int J Mol Sci. 2020;21:5657.","DOI":"10.3390\/ijms21165657"},{"key":"8935_CR48","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200054","volume":"10","author":"A Talamillo","year":"2020","unstructured":"Talamillo A, Ajuria L, Grillo M, Barroso-Gomila O, Mayor U, Barrio R. SUMOylation in the control of cholesterol homeostasis. Open Biol. 2020;10:200054.","journal-title":"Open Biol"},{"key":"8935_CR49","doi-asserted-by":"crossref","unstructured":"Sapir A. Not so slim anymore\u2014evidence for the role of SUMO in the regulation of lipid metabolism. Biomolecules. 2020;10:1154.","DOI":"10.3390\/biom10081154"},{"key":"8935_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/srep37351","volume":"6","author":"Y Liu","year":"2016","unstructured":"Liu Y, Yu F, Han Y, Li Q, Cao Z, Xiang X, et al. SUMO-specific protease 3 is a key regulator for hepatic lipid metabolism in non-alcoholic fatty liver disease. Sci Rep. 2016;6:37351.","journal-title":"Sci Rep"},{"key":"8935_CR51","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00109-024-02440-w","volume":"102","author":"Y Yang","year":"2024","unstructured":"Yang Y, Yu F. Abnormal protein SUMOylation in liver disease: novel target for therapy. J Mol Med. 2024;102:719\u201331.","journal-title":"J Mol Med"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08935-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08935-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08935-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:01:31Z","timestamp":1786629691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08935-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8935"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08935-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"718"}}